Works matching IS 03065251 AND DT 2020 AND VI 86 AND IP 4

Results: 23

Issue highlights.

Published in:: British Journal of Clinical Pharmacology, 2020, v. 86, n. 4, p. 625, doi. 10.1111/bcp.14282
Publication type:: Article

A systematic review and combined meta‐analysis of concentration of oral amisulpride.

Published in:

British Journal of Clinical Pharmacology, 2020, v. 86, n. 4, p. 668, doi. 10.1111/bcp.14246

By:

Li, Lin;
Li, Lu;
Shang, De‐Wei;
Wen, Yu‐Guan;
Ning, Yu‐Ping

Publication type:

Article

Ensuring access to safe, effective, and affordable cannabis‐based medicines.

Published in:

British Journal of Clinical Pharmacology, 2020, v. 86, n. 4, p. 630, doi. 10.1111/bcp.14242

By:

Martin, Jennifer H.;
Hall, Wayne;
Fitzcharles, Mary‐Ann;
Borgelt, Laura;
Crippa, Jose

Publication type:

Article

How the EMERGE guideline on medication adherence can improve the quality of clinical trials.

Published in:

British Journal of Clinical Pharmacology, 2020, v. 86, n. 4, p. 687, doi. 10.1111/bcp.14240

By:

Eliasson, Lina;
Clifford, Sarah;
Mulick, Amy;
Jackson, Christina;
Vrijens, Bernard

Publication type:

Article

Model‐based approach for methoxy polyethylene glycol‐epoetin beta drug development in paediatric patients with anaemia of chronic kidney disease.

Published in:

British Journal of Clinical Pharmacology, 2020, v. 86, n. 4, p. 801, doi. 10.1111/bcp.14186

By:

Chanu, Pascal;
Schaefer, Franz;
Warady, Bradley A.;
Schmitt, Claus Peter;
Reigner, Bruno;
Schnetzler, Gabriel;
Meyer Reigner, Sylvie;
Eisner, Mark;
Weichert, Arlette;
Frey, Nicolas

Publication type:

Article

Medication adherence—Key considerations for clinical pharmacologists.

Published in:

British Journal of Clinical Pharmacology, 2020, v. 86, n. 4, p. 628, doi. 10.1111/bcp.14228

By:

Hughes, Dyfrig A.

Publication type:

Article

Measuring the impact of risk communications: Robust analytical approaches are key.

Published in:

British Journal of Clinical Pharmacology, 2020, v. 86, n. 4, p. 635, doi. 10.1111/bcp.14222

By:

Arlett, Peter

Publication type:

Article

Naltrexone–bupropion (Mysimba) in management of obesity: A systematic review and meta‐analysis of unpublished clinical study reports.

Published in:

British Journal of Clinical Pharmacology, 2020, v. 86, n. 4, p. 646, doi. 10.1111/bcp.14210

By:

Onakpoya, Igho J.;
Lee, Joseph J.;
Mahtani, Kamal R.;
Aronson, Jeffrey K.;
Heneghan, Carl J.

Publication type:

Article

The efficacy and safety of fingolimod in patients with relapsing multiple sclerosis: A meta‐analysis.

Published in:

British Journal of Clinical Pharmacology, 2020, v. 86, n. 4, p. 637, doi. 10.1111/bcp.14198

By:

Yang, Ting;
Tian, Xin;
Chen, Chao‐Yang;
Ma, Ling‐Yun;
Zhou, Shuang;
Li, Min;
Wu, Ye;
Zhou, Ying;
Cui, Yi‐Min

Publication type:

Article

First‐in‐human, randomized dose‐escalation study of the safety, tolerability, pharmacokinetics, pharmacodynamics and immunogenicity of PF‐06480605 in healthy subjects.

Published in:

British Journal of Clinical Pharmacology, 2020, v. 86, n. 4, p. 812, doi. 10.1111/bcp.14187

By:

Banfield, Christopher;
Rudin, Dan;
Bhattacharya, Indranil;
Goteti, Kosalaram;
Li, Gang;
Hassan‐Zahraee, Mina;
Brown, Lisa S.;
Hung, Kenneth E.;
Pawlak, Sylvester;
Lepsy, Christopher

Publication type:

Article

Legal regulations, ethical guidelines and recent policies to increase transparency of clinical trials.

Published in:

British Journal of Clinical Pharmacology, 2020, v. 86, n. 4, p. 679, doi. 10.1111/bcp.14223

By:

Borysowski, Jan;
Wnukiewicz‐Kozłowska, Agata;
Górski, Andrzej

Publication type:

Article

Modelling pharmacokinetics and pharmacodynamics of the selective S1P<sub>1</sub> receptor modulator cenerimod in healthy subjects and systemic lupus erythematosus patients.

Published in:

British Journal of Clinical Pharmacology, 2020, v. 86, n. 4, p. 791, doi. 10.1111/bcp.14182

By:

Lott, Dominik;
Juif, Pierre‐Eric;
Dingemanse, Jasper;
Krause, Andreas

Publication type:

Article

Undergraduate and postgraduate pharmacovigilance education: A proposal for appropriate curriculum content.

Published in:

British Journal of Clinical Pharmacology, 2020, v. 86, n. 4, p. 779, doi. 10.1111/bcp.14179

By:

Herrera Comoglio, Raquel

Publication type:

Article

Evaluation of the effect of P‐glycoprotein inhibition and induction on talazoparib disposition in patients with advanced solid tumours.

Published in:

British Journal of Clinical Pharmacology, 2020, v. 86, n. 4, p. 771, doi. 10.1111/bcp.14178

By:

Elmeliegy, Mohamed;
Láng, István;
Smolyarchuk, Elena A.;
Chung, Chin‐Hee;
Plotka, Anna;
Shi, Haihong;
Wang, Diane

Publication type:

Article

Medication safety in patients with hepatic impairment: A survey of community pharmacists' knowledge level and their practice in caring for these patients.

Published in:

British Journal of Clinical Pharmacology, 2020, v. 86, n. 4, p. 763, doi. 10.1111/bcp.14177

By:

Weersink, Rianne A.;
Abadier, Marianna;
Boer, Anthonius;
Taxis, Katja;
Borgsteede, Sander D.

Publication type:

Article

Does green tea extract enhance the anti‐inflammatory effects of exercise on fat loss?

Published in:

British Journal of Clinical Pharmacology, 2020, v. 86, n. 4, p. 753, doi. 10.1111/bcp.14176

By:

Bagheri, Reza;
Rashidlamir, Amir;
Ashtary‐Larky, Damoon;
Wong, Alexei;
Alipour, Meysam;
Motevalli, Mohamad S.;
Chebbi, Amel;
Laher, Ismail;
Zouhal, Hassane

Publication type:

Article

Acute caffeine intake increases performance in the 15‐s Wingate test during the menstrual cycle.

Published in:

British Journal of Clinical Pharmacology, 2020, v. 86, n. 4, p. 745, doi. 10.1111/bcp.14175

By:

Lara, Beatriz;
Gutiérrez Hellín, Jorge;
Ruíz‐Moreno, Carlos;
Romero‐Moraleda, Blanca;
Del Coso, Juan

Publication type:

Article

Adrenal gland‐released vasostatin‐I is a myocardial depressant factor.

Published in:

British Journal of Clinical Pharmacology, 2020, v. 86, n. 4, p. 825, doi. 10.1111/bcp.14173

By:

Schneider, Francis;
Castelain, Vincent;
Herbrecht, Jean‐Etienne;
Hellé, Sophie;
Metz‐Boutigue, Marie‐Hélène

Publication type:

Article

The ABC taxonomy for medication adherence translated into French and German.

Published in:

British Journal of Clinical Pharmacology, 2020, v. 86, n. 4, p. 734, doi. 10.1111/bcp.14172

By:

Haag, Melanie;
Lehmann, Audrey;
Hersberger, Kurt E.;
Schneider, Marie‐Paule;
Gauchet, Aurélie;
Vrijens, Bernard;
Arnet, Isabelle;
Allenet, Benoît

Publication type:

Article

A phase 1/1b study of PUR1900, an inhaled formulation of itraconazole, in healthy volunteers and asthmatics to study safety, tolerability and pharmacokinetics.

Published in:

British Journal of Clinical Pharmacology, 2020, v. 86, n. 4, p. 723, doi. 10.1111/bcp.14166

By:

Hava, David L.;
Tan, Lisa;
Johnson, Patrick;
Curran, Aidan K.;
Perry, Jason;
Kramer, Steve;
Kane, Katie;
Bedwell, Pauline;
Layton, Gary;
Swann, Clarie;
Henderson, Dennis;
Khan, Naimat;
Connor, Lucy;
McKenzie, Litza;
Singh, Dave;
Roach, James

Publication type:

Article

Serious adverse effects occurring after chemotherapy: A general cancer registry‐based incidence survey.

Published in:

British Journal of Clinical Pharmacology, 2020, v. 86, n. 4, p. 711, doi. 10.1111/bcp.14159

By:

Ingrand, Isabelle;
Defossez, Gautier;
Lafay‐Chebassier, Claire;
Chavant, François;
Ferru, Aurélie;
Ingrand, Pierre;
Pérault‐Pochat, Marie‐Christine

Publication type:

Article

Impact of medicines regulatory risk communications in the UK on prescribing and clinical outcomes: Systematic review, time series analysis and meta‐analysis.

Published in:

British Journal of Clinical Pharmacology, 2020, v. 86, n. 4, p. 698, doi. 10.1111/bcp.14104

By:

Weatherburn, Christopher J.;
Guthrie, Bruce;
Dreischulte, Tobias;
Morales, Daniel R.

Publication type:

Article

Issue Information.

Published in:: British Journal of Clinical Pharmacology, 2020, v. 86, n. 4, p. 623, doi. 10.1111/bcp.14006
Publication type:: Article